Follow
Mahmudul Hasan
Mahmudul Hasan
Verified email at unmc.edu - Homepage
Title
Cited by
Cited by
Year
The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections
J Machhi, J Herskovitz, AM Senan, D Dutta, B Nath, MD Oleynikov, ...
Journal of neuroimmune pharmacology 15, 359-386, 2020
7342020
Diagnostics for SARS-CoV-2 infections
BD Kevadiya, J Machhi, J Herskovitz, MD Oleynikov, WR Blomberg, ...
Nature materials 20 (5), 593-605, 2021
7122021
Nanocarrier vaccines for SARS-CoV-2
J Machhi, F Shahjin, S Das, M Patel, MM Abdelmoaty, JD Cohen, ...
Advanced Drug Delivery Reviews 171, 215-239, 2021
922021
A role for extracellular vesicles in SARS-CoV-2 therapeutics and prevention
J Machhi, F Shahjin, S Das, M Patel, MM Abdelmoaty, JD Cohen, ...
Journal of Neuroimmune Pharmacology 16, 270-288, 2021
432021
CRISPR-Cas9 mediated exonic disruption for HIV-1 elimination
J Herskovitz, M Hasan, M Patel, WR Blomberg, JD Cohen, J Machhi, ...
EBioMedicine 73, 2021
312021
Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues
BD Kevadiya, B Ottemann, IZ Mukadam, L Castellanos, K Sikora, ...
Theranostics 10 (2), 630, 2020
312020
Humanized mice for infectious and neurodegenerative disorders
PK Dash, S Gorantla, L Poluektova, M Hasan, E Waight, C Zhang, ...
Retrovirology 18 (1), 13, 2021
202021
Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking
IZ Mukadam, J Machhi, J Herskovitz, M Hasan, MD Oleynikov, ...
Biomaterials 231, 119669, 2020
202020
Antibody-drug conjugates: a review on the epitome of targeted anti-cancer therapy
M Hasan, S Alam, SK Poddar
Current Clinical Pharmacology 13 (4), 236-251, 2018
192018
Europium-doped cerium oxide nanoparticles for microglial amyloid beta clearance and homeostasis
J Machhi, P Yeapuri, M Markovic, M Patel, W Yan, Y Lu, JD Cohen, ...
ACS chemical neuroscience 13 (8), 1232-1244, 2022
162022
The immunopathobiology of SARS-CoV-2 infection
M Patel, F Shahjin, JD Cohen, M Hasan, J Machhi, H Chugh, S Singh, ...
FEMS Microbiology Reviews 45 (6), fuab035, 2021
142021
Pharmacotherapeutics of SARS-CoV-2 infections
BD Kevadiya, J Machhi, J Herskovitz, MD Oleynikov, WR Blomberg, ...
Journal of Neuroimmune Pharmacology 16, 12-37, 2021
102021
Multipolymer microsphere delivery of SARS-CoV-2 antigens
F Shahjin, M Patel, J Machhi, JD Cohen, MU Nayan, P Yeapuri, C Zhang, ...
Acta Biomaterialia 158, 493-509, 2023
92023
Comparison between reduced susceptibility to disinfectants and multidrug resistance among hospital isolates of Pseudomonas aeruginosa and Staphylococcus aureus in Bangladesh
T Islam, SS Otun Saha, M Hridoy, M Hasan, S Marzan, MM Rahman
Bagcilar Med. Bull 2, 88-97, 2017
72017
Pathways Toward a Functional HIV-1 Cure: Balancing Promise and Perils of CRISPR Therapy
J Herskovitz, M Hasan, M Patel, BD Kevadiya, HE Gendelman
HIV Reservoirs: Methods and Protocols, 429-445, 2022
42022
Development of a porous layer-by-layer microsphere with branched aliphatic hydrocarbon porogens
F Shahjin, M Patel, M Hasan, JD Cohen, F Islam, M Ashaduzzaman, ...
Nanomedicine: Nanotechnology, Biology and Medicine 48, 102644, 2023
2023
LIPID NANOPARTICLE FORMULATIONS AND METHODS OF USE THEREOF
E GENDELMAN, Howard, J HERSKOVITZ, M HASAN, B KEVADIYA, ...
WO Patent 2022/198,229, 2022
2022
Crispr/cas9 system for multistrain hiv-1 treatment
M Hasan, J Herskovitz, H Gendelman
WO Patent WO2021178924A1, 2021
2021
Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirs
J Herskovitz, M Hasan, J Machhi, I Mukadam, BM Ottemann, JR Hilaire, ...
Nanotheranostics 5 (4), 417, 2021
2021
Exonic Disruption Facilitates Antiviral CRISPR-Cas9 Activity for Multistrain HIV-1 Elimination
J Herskovitz, M Hasan, M Patel, WR Blomberg, JD Cohen, J Machhi, ...
bioRxiv, 2021.01. 14.426544, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20